Recommendations for assessing PCOS encompass a multifaceted approach, including the evaluation of irregular menstrual cycles, ovulatory dysfunction, biochemical and clinical hyperandrogenism, ultrasound findings, serum Anti-Mullerian Hormone (AMH) levels, and various other factors such as ethnic disparities, cardiovascular disease risk, menopausal status, impaired glucose tolerance, and risk of type 2 diabetes mellitus (T2DM)(Mousa & Tay, 2023; Teede et al., 2018). This evidence concerns the gene AMH and type 2 diabetes mellitus.